小,但强大:VB_SPY_7的特征,一个针对Streptococcus PYOGENES的Lytic页面
S Rigvava1, I Kusradze2, N Karumidze3
11G. Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi; 2Caucasus International University, Tbilisi, Georgia.
Georgian medical news
|December 26, 2024
概括
使用菌体的新菌体疗法针对抗生素耐药性Streptococcus pyogenes. 菌剂提供了一种新的,持续释放的方法来治疗口腔和呼吸道感染.
科学领域:
- 微生物学 微生物学
- 细菌治疗疗法是一种细菌治疗.
- 药物输送系统 药物输送系统
背景情况:
- 像Streptococcus pyogenes这样的病原体的抗生素耐药性需要新的治疗策略.
- 菌体为治疗微生物感染提供了抗生素的有希望的替代品.
- 控制释放配方可以提高菌体治疗的疗效.
研究的目的:
- 为了描述一种新的菌体,vB_SPY_7,向Streptococcus pyogenes.
- 为了评估vB_SPY_7适合纳入Phage Pastilles,一种持续释放配方的适用性.
- 评估细菌治疗口腔和上呼吸道感染的治疗潜力.
主要方法:
- 从废水中分离和表征菌体vB_SPY_7.
- 宿主范围分析,斑块测定,吸附动力学和生长曲线研究.
- 电子显微镜和细菌的全基因组测序 vB_SPY_7.7.
主要成果:
- 菌体vB_SPY_7被确定为一种针对Streptococcus pyogenes的新型菌体.
- 基因组分析显示了35,679个基因组基因组,其中有46个预测的开放阅读框架.
- vB_SPY_7表现出高活性和可用于治疗的活力,特别是在持续释放菌片中.
结论:
- 菌体vB_SPY_7是一种对抗Streptococcus pyogenes的强有力的治疗候选者.
- 菌体 Pastilles 提供了一个有效的持续释放系统,用于菌体的输送.
- 这种方法在对抗口腔和呼吸道抗生素耐药性感染方面具有显著的潜力.
相关概念视频
01:30Lytic Cycle of Bacteriophages
69.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
69.8K
00:43Lysogenic Cycle of Bacteriophages
61.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.3K